DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vl3xng/allergic) has announced the addition of the "Allergic Rhino-Conjunctivitis - Pipeline Insights" report to their offering.
Allergic Rhino-Conjunctivitis Pipeline Insights provides the in-depth analysis of the pipeline assets across the Allergic Rhino-Conjunctivitis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Allergic Rhino-Conjunctivitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
Allergic Rhino-Conjunctivitis Pipeline Insights Report covers the Allergic Rhino-Conjunctivitis pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Allergic Rhino-Conjunctivitis related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Allergic Rhino-Conjunctivitis.
Scope
- The report provides a Allergic Rhino-Conjunctivitis Landscape across the globe
- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
- Coverage of the Allergic Rhino-Conjunctivitis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Allergic Rhino-Conjunctivitis and also provide company profiling
- Pipeline products coverage based on various stages of development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
For more information visit http://www.researchandmarkets.com/research/vl3xng/allergic
